Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response Meeting Abstract


Authors: Brahmer, J.; Horn, L.; Hossein, B.; Ramalingam, S.; Pluzanski, A.; Burgio, M. A.; Garassino, M. C.; Chow, L. Q. M.; Gettinger, S.; Crino, L.; Planchard, D.; Butts, C.; Drilon, A.; Wojcik-Tomaszewska, J.; Otterson, G.; Agrawal, S.; Li, A.; Penrod, J. R.; Antonia, S. J.; Bautista, Y.
Abstract Title: Long-term survival outcomes with nivolumab (NIVO) in pts with previously treated advanced non-small cell lung cancer (NSCLC): Impact of early disease control and response
Meeting Title: 2019 Latin America Conference on Lung Cancer
Keywords: immunotherapy; non-small cell lung cancer; nivolumab
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 11 Suppl. 2
Meeting Dates: 2019 Oct 17-19
Meeting Location: Mexico City, Mexico
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-11-01
Start Page: S1152
End Page: S1153
Language: English
ACCESSION: WOS:000494945000003
DOI: 10.1016/j.jtho.2019.09.089
PROVIDER: wos
Notes: Meeting Abstract: O.02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon